MedTrace Logo

Clinical Study of DMT in Healthy Adults

NCT05573568 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2023-02-15

No results posted yet for this study

Summary

This study aims to evaluate the acute and subacute effects of an inhaled N, N-Dimethyltryptamine in healthy individuals.

Conditions

  • Healthy Volunteers

Interventions

DRUG

N,N-Dimethyltryptamine

DMT will be administered using a vaporizer device in a single ascending fixed-order dosing regimen

Sponsors & Collaborators

  • Universidade Federal do Rio Grande do Norte

    collaborator OTHER

  • Biomind Labs Inc.

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2022-11-01
Completion
2022-11-14

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05573568 on ClinicalTrials.gov